Showing 2,301 - 2,320 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant small) OR (significant all)) decrease ))', query time: 0.63s Refine Results
  1. 2301
  2. 2302
  3. 2303
  4. 2304
  5. 2305

    Table 2_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

    Published 2025
    “…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I<sup>2</sup> = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I<sup>2</sup> = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I<sup>2</sup> = 65.5%). …”
  6. 2306

    Table 1_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

    Published 2025
    “…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I<sup>2</sup> = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I<sup>2</sup> = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I<sup>2</sup> = 65.5%). …”
  7. 2307

    Table 3_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

    Published 2025
    “…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I<sup>2</sup> = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I<sup>2</sup> = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I<sup>2</sup> = 65.5%). …”
  8. 2308
  9. 2309
  10. 2310

    Image 2_Hemoglobin glycation index and all-cause mortality in adults: insights from a decade-long prospective cohort study.tif by Yue-Yang Zhang (14258160)

    Published 2025
    “…After COX regression, restricted cubic spline analysis, and subgroup analyses, it was found that a significant increase or decrease in HGI adversely affected long-term survival.…”
  11. 2311

    Image 1_Hemoglobin glycation index and all-cause mortality in adults: insights from a decade-long prospective cohort study.tif by Yue-Yang Zhang (14258160)

    Published 2025
    “…After COX regression, restricted cubic spline analysis, and subgroup analyses, it was found that a significant increase or decrease in HGI adversely affected long-term survival.…”
  12. 2312

    Table 1_The association between oxidative balance scores and all-cause mortality and cancer-specific mortality in cancer survivors: a retrospective cohort study.doc by Ran He (207626)

    Published 2025
    “…</p>Conclusion<p>The study reveals a significant linear negative association between OBS in cancer survivors and both all-cause and cancer-specific mortality.…”
  13. 2313
  14. 2314
  15. 2315
  16. 2316
  17. 2317

    Data for Fig 6D. by Xiaohua Zhang (350570)

    Published 2024
    Subjects:
  18. 2318
  19. 2319
  20. 2320